![[feed]](/style/images/feed-icon-14x14.png){kind=icon}
Wild, C. (2005): [Erbitux®/Cetuximab for metastatic colorectal cancer]. HTA-Newsletter 40: pp. 2-3.
Preview |
PDF (HTA-Newsletter 40)
- Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
127kB |
Official URL: http://hw.oeaw.ac.at/ita/hta-newsletter?frames=yes
| Item Type: | HTA Newsletter Item |
|---|---|
| Keywords: | Erbitux, cetuximab, monoclonal antibody, metastatic colorectal cancer, second-line treatment, combination therapy |
| Subjects: | WI Digestive system > WI 400-560 Intestines QW Microbiology. Immunology WB Practice of medicine > WB 340-356 Drug Administration |
| Related URLs: | |
| References: | 1. London Cancer Drugs 2005: Cetuximab. URL: http://www.druginfozone.nhs.uk/ Record%20Viewing/viewRecord.aspx?id=553474. 2. EMEA 2004: Cetuximab. URL: http://www.emea.eu.int/humandocs/PDFs/EPAR/ erbitux/089404de1.pdf. 3. HAYES Alert 2004: Erbitux approved by FDA to treat subset of patients with colorectal cancer. 4. NHSC/GB 2002: Cetuximab for head and neck and colorectal cancer – horizon scanning review. URL: http://pcpoh.bham.ac.uk/publichealth/horizon/ PDF_files/2002reports/Cetuximab.pdf. |
| Language: | German |
| Number: | 40 |
| Deposited on: | 25 Feb 2008 19:07 |
| Last Modified: | 15 Jul 2020 17:36 |
Repository Staff Only: item control page